Leena (Dang) Dalal

At uniQure, Alnylam, and Vertex, Leena developed strategic and brand plans, led cross-functional launch teams, and built and managed marketing teams and field teams for innovative therapies. She most recently focused on leading and developing an integrated launch strategy and tactical plan for uniQure’s AMT-130, an investigational, first-in-class, disease modifying therapy for Huntington’s Disease

With over 25 years of pharmaceutical and biotechnology expertise, Leena excels in translating complex scientific concepts into actionable strategies, brand plans, business valuations, and Target Product Profiles. She has the ability to clearly communicate, critically think, and collaborate effectively; This has allowed Leena to lead and develop high performing cross-functional teams resulting in successful product launches across rare diseases and specialty conditions with high unmet needs.

Connect with Leena (Dang) Dalal on LinkedIn here.